MZF1 and asthma: However, our results suggest that HOTAIRM1, GAS5, MZF1-AS1, and OIP5-AS1 could be potential biomarkers to help clinicians accurately stratify different asthma phenotypes, which would have an indirect impact on the early diagnosis and quality of life of asthmatic patients.